Over four years after its launch, an FOI has established that the NHS will publish data from its Cannabis Patient Registry by the ‘end of the year’. Via Business of Cannabis | Europe eu1.hubs.ly/H0lWfkk0

The Care Quality Commission has raised a number of concerns related to the prescribing of cannabis-based products for medicinal use in the UK, as the latest data reveals further increases in private prescriptions. The issues raised have led to calls for a multi-agency review and

A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with cannabis use disorder (CUD) are more than three times more likely to develop oral cancer within five years compared to those without CUD.

A new study confirms the first direct link between an invasive fungal infection and a medical cannabis product in the US, revealing a significant public health risk for immunocompromised patients.France to formally integrate medical cannabis into its national healthcare system

A new study confirms the first direct link between an invasive fungal infection and a medical cannabis product in the US, revealing a significant public health risk for immunocompromised patients. Read more: eu1.hubs.ly/H0md5mx0

New research on 25,000 adults aged 44–81 links cannabis use to slower brain ageing and improved cognition, with users showing brain traits typical of younger adults and enhanced cognitive abilities. Read the full article here: eu1.hubs.ly/H0mjjhx0

How can policy better meet patient needs in medicinal cannabis? 🤔 The Cannabis Health Symposium lands in London, Q4 2025. Join us for a one-day symposium designed to provide UK healthcare professionals with expert-led, clinically grounded education on cannabis-based medicinal

A new survey of NHS doctors has highlighted a growing demand for alternative treatment options for complex health issues such as chronic pain and women’s health-related concerns. Out of 500 doctors currently practicing in the NHS, almost half of which were GPs, three quarters

In an email sent to patients on Monday 18 August, CB1 Medical confirmed it had identified a ‘data security incident’ when patients’ personal details, including prescription information, were found on a file hosting website. eu1.hubs.ly/H0msn-K0

The systematic review found that improved orgasm function, including increased frequency, intensity, quality, ease, satisfaction, and the ability to experience multiple orgasms per sexual encounter, was reported in all nine studies that evaluated #cannabis use before sexual

The UK’s medical cannabis sector is expanding quickly, with prescriptions rising 130% last year. How can the healthcare sector and industry work together to close this gap? Releaf eu1.hubs.ly/H0mDGMg0

Cannabis Health will host its first in-person, expert-led educational event for UK healthcare professionals on Tuesday, 25 November 2025, London. The CPD-accredited Cannabis Health Symposium aims to bridge the gap between policy and patient access. 🔗 eu1.hubs.ly/H0mF7b50

Following our announcement of the Cannabis Health Symposium, we’re excited to share the full details of this one-day event for UK healthcare professionals. 📍 Conway Hall, London 🗓️ 25 November 2025 Tickets available—first come, first served 🎟️👉 eu1.hubs.ly/H0mFdJ20

.Curaleaf Laboratories has today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Since medical cannabis was legalised in the UK in 2018, one of the biggest unmet patient needs has been a

UK CBD regulation advances: Nearly 3,000 CBD isolate products reach final phase of FSA novel foods approval after new public consultation. Read the full story here: eu1.hubs.ly/H0mKMHc0

Two new studies, one a large meta-analysis and the other real-world evidence from the UK, suggest that cannabis-based medicines, particularly those containing THC or mixed cannabinoids, may improve sleep quality and ease symptoms of insomnia. eu1.hubs.ly/H0mMVpq0

A major new study, analysing data from over four million adults in the US and Europe, has linked cannabis use to an almost quadrupling in the risk of developing type 2 diabetes. eu1.hubs.ly/H0n3SYq0

Cannabis Health and MCCS bring vital clinician-led education to the UK. Cannabis Health has partnered with leading experts at the Medical Cannabis Clinicians Society (MCCS) to bring its first educational event for healthcare professionals to the UK later this year. The Cannabis

Become a Partner 🤝 We're looking for partners for our upcoming Symposium, this November. This is a unique opportunity to position your brand at the forefront of medical cannabis innovation and education in the UK. Gain high-impact visibility through panel speaking

A Yorkshire man, who supplied cannabis products to thousands of people with chronic illnesses, has been jailed for four years after his original suspended sentence was overturned. 🔗eu1.hubs.ly/H0njVBQ0